| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/14/2009 | CN100450509C Medicinal composition for treating hepatitis |
| 01/14/2009 | CN100450508C Medicinal compositions comprising biphenyldicarboxylate |
| 01/14/2009 | CN100450507C Chinese traditional medicine and western medicine composition for treating hepatitis |
| 01/14/2009 | CN100450506C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 01/14/2009 | CN100450505C Chinese medicinal ointment for treating beriberi |
| 01/14/2009 | CN100450499C Accessory drug for treating hepatitis |
| 01/14/2009 | CN100450498C Accessory medicinal composition for treating hepatitis |
| 01/14/2009 | CN100450484C Imiquimod turbid liquor and gelling agent thereof |
| 01/14/2009 | CN100450479C Medication in use for bacteriostasis and antiinflammation |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476693 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476666 HIV integrase inhibitors |
| 01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |
| 01/13/2009 | US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | CA2605226C Nucleotide analog composition and synthesis method |
| 01/13/2009 | CA2382654C Novel a-500359 derivatives |
| 01/13/2009 | CA2315975C Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/13/2009 | CA2233932C Vaccines against infections caused by yf virus; yf infectious cdna, method for producing a recombinant yf virus from the yf infectious cdna and plasmids to assemble the yf infectious cdna |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/09/2009 | CA2623769A1 Composition and method for the prevention of oral disease |
| 01/08/2009 | WO2009006203A1 Therapeutic compositions and the use thereof |
| 01/08/2009 | WO2009006199A1 Therapeutic compositions and the use thereof |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005877A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | WO2009005870A2 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 01/08/2009 | WO2009005693A1 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | WO2009005687A1 Purine derivatives and their use as modulators of toll-like receptor 7 |
| 01/08/2009 | WO2009005674A2 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | WO2009005379A1 New medical applications of alpha-ketoglutarate |
| 01/08/2009 | WO2009005338A2 Solid forms ult-i, ult-2 and ult-3 of emtricitabine |
| 01/08/2009 | WO2009005123A1 INTERFERON-β PRODUCTION PROMOTER, AND METHOD FOR PRODUCTION THEREOF |
| 01/08/2009 | WO2009005095A1 Treatment of influenza |
| 01/08/2009 | WO2009005077A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 01/08/2009 | WO2009004914A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group |
| 01/08/2009 | WO2009004842A1 Vaccine for swine edema disease |
| 01/08/2009 | WO2009004339A2 Modulation of reactive oxygen species in the treatment of respiratory infection |
| 01/08/2009 | WO2009004322A2 Derivatives of nystatin and their use as antifungal agents |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | WO2009003975A1 Antibodies against human cytomegalovirus (hcmv) |
| 01/08/2009 | WO2009003711A2 Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 01/08/2009 | WO2009003595A2 Macrolactone derivatives |
| 01/08/2009 | WO2009003492A1 Mhc multimers, methods for their generation, labeling and use |
| 01/08/2009 | WO2009003463A2 Use of deuterium oxide for treating virus-based skin diseases |
| 01/08/2009 | WO2009003307A1 Phthiobuzonum derivatives and preparation, pharmaceutical composition and use thereof |
| 01/08/2009 | WO2009003291A1 Therapeutics and diagnostics for group a streptococci |
| 01/08/2009 | WO2008141010A3 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 01/08/2009 | WO2008140582A3 Production of anti-microbial peptides |
| 01/08/2009 | WO2008139402A3 A method of inhibiting hiv replication |
| 01/08/2009 | WO2008138079A3 Use of nucleoside derivatives as anti-koi herpes virus in fish |
| 01/08/2009 | WO2008137779A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 01/08/2009 | WO2008127275A3 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 01/08/2009 | WO2008115385A3 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 01/08/2009 | WO2008091659A3 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012137 Antmicrobial and radioprotective compounds |
| 01/08/2009 | US20090012113 Administering rifaximin to the subject |
| 01/08/2009 | US20090012111 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 01/08/2009 | US20090012107 Antiviral Compounds and Methods of Using Thereof |
| 01/08/2009 | US20090012092 Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives |
| 01/08/2009 | US20090012072 Fluoroquinolone compositions |
| 01/08/2009 | US20090012071 4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,9h)-diones and related compounds as anti-infective agents |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012054 Cephem Compounds and Use as Antimicrobial Agents |
| 01/08/2009 | US20090012048 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection |
| 01/08/2009 | US20090012046 Methods of Treating Mutated Hiv |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012039 Use of methylcobalamin nasal spray to treat disorders |
| 01/08/2009 | US20090012038 Methods for microbial biofilm destruction and interference with microbial cellular physiology |
| 01/08/2009 | US20090012034 Non-Nucleoside reverse transcriptase inhibitors |
| 01/08/2009 | US20090012032 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
| 01/08/2009 | US20090012031 EZH2 Cancer Markers |
| 01/08/2009 | US20090012025 Methods and Compositions for Treatment of Sepsis |
| 01/08/2009 | US20090012022 Hybrid Interfering Rna |
| 01/08/2009 | US20090012017 Polypeptide Complex that Regulates Cell Cycle and Anergy |
| 01/08/2009 | US20090012015 Large dose ribavrin formulatons |
| 01/08/2009 | US20090012000 Anti-Viral Peptide and Use Thereof |
| 01/08/2009 | US20090011996 Diagnosing and protecting horses against papillomavirus |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011977 Novel Lipopeptides as Antibacterial Agents |
| 01/08/2009 | US20090011974 Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011053 METHOD OF DELETING nef GENE IN HIV-1 USING RED GINSENG |
| 01/08/2009 | US20090011052 Anti-HIV medicinal herbs composition, preparation thereof and use of the same |
| 01/08/2009 | US20090011023 Chemotherapeutic compositions |
| 01/08/2009 | US20090011022 Use of deuterium oxide for treatment of virus-based diseases of the skin |
| 01/08/2009 | US20090011020 Gastroresistant Pharmaceutical Formulations Containing Rifaximin |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010980 Materials coatings and methods for self-cleaning and self-decontamination of metal surface |
| 01/08/2009 | US20090010963 Raccoon Poxvirus Expressing Rabies Glycoproteins |
| 01/08/2009 | US20090010962 Genetically Engineered Swine Influenza Virus and Uses Thereof |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010960 Bacteriophage-mediated immunisation against hepatitis |
| 01/08/2009 | US20090010956 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 01/08/2009 | US20090010955 Vaccines Containing Canine Parvovirus Genetic Variants |